ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 143241 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 143241; 2) Community: the network communities that were significantly associated with the response to NSC 143241; 3) Molecule: the relationships between components within communities and NSC 143241; 4) MDR: the compounds that were significantly associated with the NSC 143241.

NSC Compound Enrichment Correlation
NSC 150862 BLEOMYCIN FRACTION BLM-HPE 0.043472147060915 -0.048272006
NSC 155693 6H-Pyrido[4,3-b]carbazolium, 9-methoxy-2,5,11-trimethyl-,iodide 0.043472147060915 -0.16069702
NSC 159631 Ergochrome AA (2,2')-5-.beta.,6-.alpha.,10-.beta.-5',6'-.alpha.,10'-.beta. 0.043472147060915 0.33826409
NSC 175633 4(1H)-Quinazolinone, 2-(2-chlorophenyl)-2,3-dihydro- 0.043472147060915 0.68344134
NSC 180973 Tamoxifen citrate 0.043472147060915 0.41186599
NSC 266491 Psorspermin 0.043472147060915 0.42619752
NSC 278631 2-Butenoic acid, 3-[(1,3-dihydroxy-2-naphthalenyl)thio]-, ethyl ester, (Z)- 0.043472147060915 -0.00042686476
NSC 309401 2H-Pyrrolo[3,2-f]quinazoline-2,4(3H)-diamine, 3-[(3-aminophenyl)methyl]-, dihydrochloride 0.043472147060915 0.25776342
NSC 32937 Benzenamine, 4-(9-chloro-10-ethyl-9,10-dihydro-9-acridinyl)-N,N-dimethyl-, dihydrochloride 0.043472147060915 0.2054754
NSC 329691 HM-4 0.043472147060915 0.14690621
Total:105  Current:93    [First] [Prev] [Next] [Last]